Stammdaten
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
Unternehmen & Branche
| Name | Nuo Therapeutics, Inc. |
|---|---|
| Ticker | AURX |
| CIK | 0001091596 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 59,3 Mio. USD |
| Beta | -104,09 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | -2,512,216 | 1,845,662 | -956,559 | ||
| 2025-09-30 | 10-Q | -537,919 | 1,927,637 | -419,606 | ||
| 2025-06-30 | 10-Q | -649,689 | 1,359,485 | -824,561 | ||
| 2025-03-31 | 10-Q | -746,128 | 1,146,754 | -213,073 | ||
| 2024-12-31 | 10-K | -2,323,705 | 1,189,508 | 513,712 | ||
| 2024-09-30 | 10-Q | -578,167 | 1,719,103 | 890,387 | ||
| 2024-06-30 | 10-Q | -540,091 | 1,420,472 | 598,513 | ||
| 2024-03-31 | 10-Q | -708,781 | 1,242,833 | 333,448 | ||
| 2023-12-31 | 10-K | -3,171,436 | 1,877,880 | 1,039,148 | ||
| 2023-09-30 | 10-Q | -790,640 | 1,599,902 | 726,722 | ||
| 2023-06-30 | 10-Q | -871,886 | 1,385,279 | 470,835 | ||
| 2023-03-31 | 10-Q | -855,755 | 2,220,795 | 1,338,003 | ||
| 2022-12-31 | 10-K | -3,171,736 | 3,047,360 | 2,191,338 | ||
| 2022-09-30 | 10-Q | -912,789 | 3,864,812 | 3,150,658 | ||
| 2022-06-30 | 10-Q | -924,050 | 4,323,151 | 3,562,011 | ||
| 2022-03-31 | 10-Q | -375,380 | 1,058,200 | 527,222 | ||
| 2021-12-31 | 10-K | -90,670 | -0.03 | 1,465,918 | 792,839 | |
| 2021-09-30 | 10-Q | -6,751 | 0.00 | 149,930 | -523 | |
| 2021-09-30 | 10-K | -6,751 | 149,930 | -522,537 | ||
| 2021-06-30 | 10-K | -6,546 | 153,085 | -515,786 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.